BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes

  April 15, 2026

   · 

  2 min read
• Press Releases

  Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026

  April 15, 2026

   · 

  1 min read
• Press Releases

  Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

  April 15, 2026

   · 

  1 min read
• Press Releases

  Gene Therapy Clinical Trials Market Size to grow to USD 3.29 Bn by 2035 at CAGR 9.24%

  April 15, 2026

   · 

  1 min read
• Press Releases

  Cell and Gene Therapy CDMO Market to Hit Around USD 125.09 Bn by 2035

  April 15, 2026

   · 

  1 min read
• Press Releases

  C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution

  April 15, 2026

   · 

  1 min read
• 

  Press Releases

  Yellowbird Diagnostics Announces First Patients Dosed in Phase 1 Trial of NeuCavis(TM)

  Novel metabolic imaging agent identifies inflammation with high specificity

  April 15, 2026

   · 

  2 min read
• Press Releases

  TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI

  April 15, 2026

   · 

  14 min read
• Press Releases

  neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

  April 15, 2026

   · 

  9 min read
• Press Releases

  Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

  April 15, 2026

   · 

  8 min read